Research Article
Metabolic Tumor Volume by 18F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors
Table 1
Clinical characteristics of patients.
| | Characteristics | Value |
| | Total number of patients | 27 (100%) | | Sex | | | Male | 13 (48%) | | Female | 14 (52%) | | Age (years) mean (range) | 53.9 (12–82) | | Location | | | Cervical | 7 (26%) | | Thoracic | 10 (37%) | | Lumbar | 6 (22%) | | Sacral | 4 (15%) | | Size | | | ≧5 cm | 14 (52%) | | <5 cm | 13 (48%) | | Histology | | | MPNST | 5 | | UPS | 4 | | Osteosarcoma | 3 | | Chondrosarcoma | 3 | | Leiomyosarcoma | 2 | | Chordoma | 2 | | GCTB | 2 | | Others | 6 | | Surgery | | | Total | 16 (59%) | | with wide margin | 5 | | Chemotherapy | 15 (56%) | | Radiotherapy | 16 (59%) |
|
|
MPNST: malignant peripheral nerve sheath tumor, UPS: undifferentiated pleomorphic sarcoma, and GCTB: giant cell tumor of bone.
|